+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Surgical Devices Market Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis

  • PDF Icon

    Report

  • 120 Pages
  • November 2021
  • Region: Global
  • Renub Research
  • ID: 5504329
Cardiovascular diseases, or CVDs, have continued to be considered among the top pain counts of medical applications worldwide. Globally, cardiovascular devices are being used in the diagnosis of heart diseases and treatment of heart-related problems. Besides, these devices actively facilitate to repair of structural defects of the cardiovascular system of the heart, and its damaged or blocked valves and vessels. In addition, with conditions like stroke or IHD (ischemic heart disease) adding heavily to death and disability, cardiovascular surgical devices and their consequence in heart-related therapies has been quickly brought into the spotlight in recent years. According to the publisher analysis, Global Cardiovascular Surgical Devices Market is projected to reach US$ 69.74 Billion by 2027.



Impact of Covid-19 on Cardiovascular Surgical Devices Industry


The COVID-19 had negatively affected the global cardiovascular surgical devices industry during the initial period of 2020. The outbreak of Covid-19 announced the emergence of healthcare by the World Health Organization (WHO). Besides, the governments imposed nationwide lockdown and a ban on flights.

In addition, due to the sudden lockdown, the concerned activities on cardiac surgeries stopped and postponed; the market experienced a downfall. However, the latter period of the pandemic shows the significant growth of the market. Moreover, the usage of cardiac surgeries has been increased, and the market experienced the foremost growth. The market shares are expected to have their average growth with the ascendance of the year 2021.

Cardiology Devices Improved Significantly & Indications Expanded


Over the past decade, technologies used to develop cardiology devices have improved significantly, and indications for these devices have expanded. Further, an increasing number of patients being managed with cardiology devices, exponential therapeutically, and monitoring outcomes have also driven the market. Remarkably, artificial intelligence is an advancement that positively impacts cardiovascular devices with improved capabilities to diagnose certain heart conditions.

For instance, in October 2020, GE Healthcare received the US FDA 510k clearance for its ultra-edition package of vivid cardiovascular ultrasound systems, including new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

Worldwide Cardiovascular Surgical Device Market Size was US$ 49.77 Billion in 2021


By Type, the publisher holds meaningful existence of devices like Perfusion Disposables, Cardiopulmonary Bypass Equipment, Beating Heart Surgery Treatment and Ventricular Assist Device in the Global Cardiovascular Surgical Devices Market. Wherein, the rising prevalence of atrial fibrillation is an essential contributor to the popularity of these devices. Remarkably, in cardiac ablation device technologies, the products inscribe an ever-increasing demand for minimally invasive ablation procedures and discovery.

Heart Failure and Arrhythmia Fuelled Cardiac Rhythm Management (CRM)

In the report, By Application, we have covered interventional cardiac surgery, cardiac rhythm management and traditional cardiac surgery. Increased heart failure and arrhythmia have fuelled the demand for technologically advanced cardiac rhythm management (CRM) devices. Cardiac rhythm management devices manage and monitor cardiac issues and have applications in repairing, restoring, and healing cardiac activities. Moreover, owing to the increasing life expectancy and availability of advanced technologies, the adoption of cardiac rhythm management devices has also increased in the past few years.

Global Cardiovascular Surgical Devices Industry will grow with a CAGR of 5.78% during 2021-2027


By end-user, the market is segregated into hospitals, cardiac diagnostic centres and ambulatory surgical centres. The well-developed infrastructure, high footfall, and increased healthcare expenditure have made the hospital the most preferred end-use extension. Moreover, a surge in the volume of surgeries due to the expanding prevalence of heart diseases and other disorders in hospitals is expected to boost the segment's growth over the forecast period. In addition, the high demand for cardiac surgeries is increasing the number of operating rooms aiding the development of the part, correspondingly boosting the growth of the Global Cardiovascular Surgical Devices Market.

North America dominated the market share for Global Cardiovascular Surgical Devices Market


North America dominates the market owing to a well-established healthcare division. An increasing number of surgeries and a thriving prevalence of cardiac dysfunctions are also anticipated to drive the region. Moreover, the massive adoption of advanced tools and devices for surgeries propels growth.

Similarly, Asia Pacific also has a significant market in respect of the market share. Development in healthcare facilities and reimbursement schemes in developing economies are vital factors aiding growth. China owing to the high geriatric population and a fast developing economy, significantly contributes to the market. Besides, a growing number of cardiac surgeries are anticipated to support growth during the forecast period.

Prominent Companies in Global Cardiovascular Surgical Devices Market Insights


Some prominent players are Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Cardinal Health Inc., Medtronic PLC and GE Healthcare. In the report we have covered the players who have been launching different products & accessories and are involved in technological advancements and strategic initiatives, such as mergers & acquisitions.

This report “Cardiovascular Surgery Devices Market, Global Forecast By Type (Perfusion Disposables, Cardiopulmonary Bypass Equipment, Beating Heart Surgery Treatment and Ventricular Assist Device), Application (Interventional Cardiac Surgery, Cardiac Rhythm Management, Traditional Cardiac Surgery and Others), End-User (Hospitals, Cardiac Diagnostic Centres and Ambulatory Surgical Centre), Region (North America, Europe, Asia Pacific and Rest of World), Companies (Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Cardinal Health Inc., Medtronic PLC and GE Healthcare)” provides a detailed analysis of Cardiovascular Surgery DevicesIndustry.

Type - Global Cardiovascular Surgery Devices Markethave been covered from 4 viewpoints:


1. Perfusion Disposables
2. Cardiopulmonary Bypass Equipment
3. Beating Heart Surgery Treatment
4. Ventricular Assist Device

Application - Global Cardiovascular Surgery Devices Market have been covered from 4 viewpoints:


1. Interventional Cardiac Surgery
2. Cardiac Rhythm Management
3. Traditional Cardiac Surgery
4. Others

End-Use - Global Cardiovascular Surgery Devices Market have been covered from 3 viewpoints:


1. Hospitals
2. Cardiac Diagnostic Centres
3. Ambulatory Surgical Centre

Region - Global Cardiovascular Surgery Devices Market have been covered from 4 viewpoints:


1. North America
2. Europe
3. Asia Pacific
4. Rest of World

Company Insights:

  • Overview
  • Recent Development
  • Revenue

Companies Covered:


1. Abbott Laboratories
2. Boston Scientific Corporation
3. Edwards Lifesciences
4. Cardinal Health Inc.
5. Medtronic PLC
6. GE Healthcare
Frequently Asked Questions about the Global Cardiovascular Surgical Devices Market

What is the estimated value of the Global Cardiovascular Surgical Devices Market?

The Global Cardiovascular Surgical Devices Market was estimated to be valued at $49.77 Billion in 2021.

What is the growth rate of the Global Cardiovascular Surgical Devices Market?

The growth rate of the Global Cardiovascular Surgical Devices Market is 5.8%, with an estimated value of $69.74 Billion by 2027.

What is the forecasted size of the Global Cardiovascular Surgical Devices Market?

The Global Cardiovascular Surgical Devices Market is estimated to be worth $69.74 Billion by 2027.

Who are the key companies in the Global Cardiovascular Surgical Devices Market?

Key companies in the Global Cardiovascular Surgical Devices Market include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Cardinal Health Inc. and GE Healthcare.

Table of Contents

1. Introduction2. Research & Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Cardiovascular Surgery Devices Market
6. Market Share – Global Cardiovascular Surgery Devices
6.1 By Type
6.2 By Application
6.3 By End-Use
6.4 By Region
7. Type - Global Cardiovascular Surgery Devices Market
7.1 Perfusion Disposables
7.2 Cardiopulmonary Bypass Equipment
7.3 Beating Heart Surgery Treatment
7.4 Ventricular Assist Device
8. Application - Global Cardiovascular Surgery Devices Market
8.1 Interventional Cardiac Surgery
8.2 Cardiac Rhythm Management
8.3 Traditional Cardiac Surgery
8.4 Others
9. End-Use - Global Cardiovascular Surgery Devices Market
9.1 Hospitals
9.2 Cardiac Diagnostic Centres
9.3 Ambulatory Surgical Centre
10. Region - Global Cardiovascular Surgery Devices Market
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 ROW
11. Company Analysis
11.1 Abbott Laboratories
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Revenue
11.2 Boston Scientific Corporation
11.2.1 Overview
11.2.2 Recent Development
11.2.3 Revenue
11.3 Edwards Lifesciences
11.3.1 Overview
11.3.2 Recent Development
11.3.3 Revenue
11.4 Cardinal Health Inc.
11.4.1 Overview
11.4.2 Recent Development
11.4.3 Revenue
11.5 Medtronic PLC
11.5.1 Overview
11.5.2 Recent Development
11.5.3 Revenue
11.6 GE Healthcare
11.6.1 Overview
11.6.2 Recent Development
11.6.3 Revenue
List Of Figures:
Figure-01: Global Cardiovascular Surgery Devices Market (Billion US$), 2016 – 2021
Figure-02: Forecast for – Global Cardiovascular Surgery Devices Market (Billion US$), 2022 – 2027
Figure-03: Type – Perfusion Disposables Market (Million US$), 2016 – 2021
Figure-04: Type – Forecast for Perfusion Disposables Market (Million US$), 2022 – 2027
Figure-05: Type – Cardiopulmonary Bypass Equipment Market (Million US$), 2016 – 2021
Figure-06: Type – Forecast for Cardiopulmonary Bypass Equipment Market (Million US$), 2022 – 2027
Figure-07: Type – Beating Heart Surgery Treatment Market (Million US$), 2016 – 2021
Figure-08: Type – Forecast for Beating Heart Surgery Treatment Market (Million US$), 2022 – 2027
Figure-09: Type – Ventricular Assist Device Market (Million US$), 2016 – 2021
Figure-10: Type – Forecast for Ventricular Assist Device Market (Million US$), 2022 – 2027
Figure-11: Application – Interventional Cardiac Surgery Market (Million US$), 2016 – 2021
Figure-12: Application – Forecast for Interventional Cardiac Surgery Market (Million US$), 2022 – 2027
Figure-13: Application – Cardiac Rhythm Management Market (Million US$), 2016 – 2021
Figure-14: Application – Forecast for Cardiac Rhythm Management Market (Million US$), 2022 – 2027
Figure-15: Application – Traditional Cardiac Surgery Market (Million US$), 2016 – 2021
Figure-16: Application – Forecast for Traditional Cardiac Surgery Market (Million US$), 2022 – 2027
Figure-17: Application – Others Market (Million US$), 2016 – 2021
Figure-18: Application – Forecast for Others Market (Million US$), 2022 – 2027
Figure-19: End-User – Hospitals Market (Million US$), 2016 – 2021
Figure-20: End-User – Forecast for Hospitals Market (Million US$), 2022 – 2027
Figure-21: End-User – Cardiac Diagnostic Centres Market (Million US$), 2016 – 2021
Figure-22: End-User – Forecast for Cardiac Diagnostic Centres Market (Million US$), 2022 – 2027
Figure-23: End-User – Ambulatory Surgical Centre Market (Million US$), 2016 – 2021
Figure-24: End-User – Forecast for Ambulatory Surgical Centre Market (Million US$), 2022 – 2027
Figure-25: North America – Cardiovascular Surgery Devices Market (Million US$), 2016 – 2021
Figure-26: North America – Forecast for Cardiovascular Surgery Devices Market (Million US$), 2022 – 2027
Figure-27: Europe – Cardiovascular Surgery Devices Market (Million US$), 2016 – 2021
Figure-28: Europe – Forecast for Cardiovascular Surgery Devices Market (Million US$), 2022 – 2027
Figure-29: Asia Pacific – Cardiovascular Surgery Devices Market (Million US$), 2016 – 2021
Figure-30: Asia Pacific – Forecast for Cardiovascular Surgery Devices Market (Million US$), 2022 – 2027
Figure-31: Rest of World – Cardiovascular Surgery Devices Market (Million US$), 2016 – 2021
Figure-32: Rest of World – Forecast for Cardiovascular Surgery Devices Market (Million US$), 2022 – 2027
Figure-33: Abbott Laboratories – Global Revenue (Million US$), 2016 – 2021
Figure-34: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-35: Boston Scientific Corporation – Global Revenue (Million US$), 2016 – 2021
Figure-36: Boston Scientific Corporation – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-37: Edwards Lifesciences – Global Revenue (Million US$), 2016 – 2021
Figure-38: Edwards Lifesciences – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-39: Cardinal Health Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-40: Cardinal Health Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-41: Medtronic PLC – Global Revenue (Million US$), 2016 – 2021
Figure-42: Medtronic PLC – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-43: GE Healthcare – Global Revenue (Million US$), 2016 – 2021
Figure-44: GE Healthcare – Forecast for Global Revenue (Million US$), 2022 – 2027
List Of Tables:
Table-01: Global – Cardiovascular Surgery Devices Market Share by Type (Percent), 2016 – 2021
Table-02: Global – Forecast for Cardiovascular Surgery Devices Market Share by Type (Percent), 2022 – 2027
Table-03: Global – Cardiovascular Surgery Devices Market Share by Application (Percent), 2016 – 2021
Table-04: Global – Forecast for Cardiovascular Surgery Devices Market Share by Application (Percent), 2022 – 2027
Table-05: Global – Cardiovascular Surgery Devices Market Share by End-User (Percent), 2016 – 2021
Table-06: Global – Forecast for Cardiovascular Surgery Devices Market Share by End-User (Percent), 2022 – 2027
Table-07: Global – Cardiovascular Surgery Devices Market Share by Region (Percent), 2016 – 2021
Table-08: Global – Forecast for Cardiovascular Surgery Devices Market Share by Region (Percent), 2022 – 2027

Companies Mentioned

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • Cardinal Health Inc.
  • Medtronic PLC
  • GE Healthcare

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...